AMGEN INC (1AMGN.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1AMGN - US0311621009 - Common Stock
277.8 EUR
-0.65 (-0.23%)
Taking everything into account, 1AMGN scores 5 out of 10 in our fundamental rating. 1AMGN was compared to 86 industry peers in the Biotechnology industry. While 1AMGN has a great profitability rating, there are quite some concerns on its financial health. 1AMGN has a decent growth rate and is not valued too expensively. 1AMGN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
- 1AMGN had positive earnings in the past year.
- In the past year 1AMGN had a positive cash flow from operations.
- 1AMGN had positive earnings in each of the past 5 years.
- Each year in the past 5 years 1AMGN had a positive operating cash flow.
1.2 Ratios
- 1AMGN's Return On Assets of 7.77% is amongst the best of the industry. 1AMGN outperforms 86.05% of its industry peers.
- 1AMGN's Return On Equity of 72.82% is amongst the best of the industry. 1AMGN outperforms 100.00% of its industry peers.
- The Return On Invested Capital of 1AMGN (15.39%) is better than 91.86% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for 1AMGN is in line with the industry average of 11.58%.
- The last Return On Invested Capital (15.39%) for 1AMGN is above the 3 year average (13.04%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROIC | 15.39% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
1.3 Margins
- 1AMGN has a Profit Margin of 19.47%. This is amongst the best in the industry. 1AMGN outperforms 86.05% of its industry peers.
- 1AMGN's Profit Margin has declined in the last couple of years.
- 1AMGN has a Operating Margin of 33.57%. This is amongst the best in the industry. 1AMGN outperforms 91.86% of its industry peers.
- 1AMGN's Operating Margin has declined in the last couple of years.
- 1AMGN's Gross Margin of 72.06% is fine compared to the rest of the industry. 1AMGN outperforms 65.12% of its industry peers.
- 1AMGN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% |
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1AMGN is creating some value.
- The number of shares outstanding for 1AMGN has been increased compared to 1 year ago.
- 1AMGN has less shares outstanding than it did 5 years ago.
- 1AMGN has a better debt/assets ratio than last year.
2.2 Solvency
- The Debt to FCF ratio of 1AMGN is 4.28, which is a neutral value as it means it would take 1AMGN, 4.28 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 4.28, 1AMGN belongs to the best of the industry, outperforming 80.23% of the companies in the same industry.
- A Debt/Equity ratio of 5.45 is on the high side and indicates that 1AMGN has dependencies on debt financing.
- With a Debt to Equity ratio value of 5.45, 1AMGN is not doing good in the industry: 61.63% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Altman-Z | N/A |
ROIC/WACC1.78
WACC8.65%
2.3 Liquidity
- 1AMGN has a Current Ratio of 1.28. This is a normal value and indicates that 1AMGN is financially healthy and should not expect problems in meeting its short term obligations.
- 1AMGN has a worse Current ratio (1.28) than 65.12% of its industry peers.
- 1AMGN has a Quick Ratio of 1.28. This is a bad value and indicates that 1AMGN is not financially healthy enough and could expect problems in meeting its short term obligations.
- 1AMGN has a worse Quick ratio (0.99) than 63.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
- 1AMGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.79%, which is quite good.
- 1AMGN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.97% yearly.
- 1AMGN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.56%.
- 1AMGN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.43% yearly.
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
3.2 Future
- Based on estimates for the next years, 1AMGN will show a small growth in Earnings Per Share. The EPS will grow by 4.48% on average per year.
- Based on estimates for the next years, 1AMGN will show a small growth in Revenue. The Revenue will grow by 3.55% on average per year.
EPS Next Y9.43%
EPS Next 2Y6.17%
EPS Next 3Y5.25%
EPS Next 5Y4.48%
Revenue Next Year9.42%
Revenue Next 2Y5.5%
Revenue Next 3Y4.54%
Revenue Next 5Y3.55%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 14.78, the valuation of 1AMGN can be described as correct.
- Based on the Price/Earnings ratio, 1AMGN is valued cheaper than 91.86% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 26.94. 1AMGN is valued slightly cheaper when compared to this.
- Based on the Price/Forward Earnings ratio of 14.46, the valuation of 1AMGN can be described as correct.
- Based on the Price/Forward Earnings ratio, 1AMGN is valued cheaper than 91.86% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 23.94, 1AMGN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.78 | ||
| Fwd PE | 14.46 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 1AMGN is valued cheaper than 83.72% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, 1AMGN is valued cheaply inside the industry as 91.86% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.64 | ||
| EV/EBITDA | 12.4 |
4.3 Compensation for Growth
- 1AMGN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- 1AMGN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.57
PEG (5Y)2.47
EPS Next 2Y6.17%
EPS Next 3Y5.25%
5. Dividend
5.1 Amount
- 1AMGN has a Yearly Dividend Yield of 3.11%.
- Compared to an average industry Dividend Yield of 0.75, 1AMGN pays a better dividend. On top of this 1AMGN pays more dividend than 95.35% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.83, 1AMGN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
5.2 History
- On average, the dividend of 1AMGN grows each year by 9.41%, which is quite nice.
Dividend Growth(5Y)9.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 1AMGN pays out 17.20% of its income as dividend. This is a sustainable payout ratio.
- 1AMGN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP17.2%
EPS Next 2Y6.17%
EPS Next 3Y5.25%
BIT:1AMGN (1/12/2026, 7:00:00 PM)
277.8
-0.65 (-0.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-02 2026-02-02/amc
Inst Owners83.83%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap149.59B
Revenue(TTM)35.97B
Net Income(TTM)7.00B
Analysts72.2
Price Target289.78 (4.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
Yearly Dividend7.7
Dividend Growth(5Y)9.41%
DP17.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.96%
Min EPS beat(2)10.28%
Max EPS beat(2)11.64%
EPS beat(4)4
Avg EPS beat(4)9.04%
Min EPS beat(4)2.49%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)5.13%
EPS beat(12)10
Avg EPS beat(12)4.44%
EPS beat(16)14
Avg EPS beat(16)4.21%
Revenue beat(2)2
Avg Revenue beat(2)2.59%
Min Revenue beat(2)0.68%
Max Revenue beat(2)4.49%
Revenue beat(4)3
Avg Revenue beat(4)1.17%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.49%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)4
Avg Revenue beat(12)-0.48%
Revenue beat(16)5
Avg Revenue beat(16)-0.54%
PT rev (1m)5.64%
PT rev (3m)3.43%
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)-11.17%
EPS NY rev (1m)1.12%
EPS NY rev (3m)2.12%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)1.93%
Revenue NY rev (1m)1.86%
Revenue NY rev (3m)2.89%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.78 | ||
| Fwd PE | 14.46 | ||
| P/S | 4.84 | ||
| P/FCF | 13.64 | ||
| P/OCF | 13.26 | ||
| P/B | 18.09 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.4 |
EPS(TTM)18.8
EY6.77%
EPS(NY)19.21
Fwd EY6.91%
FCF(TTM)20.37
FCFY7.33%
OCF(TTM)20.96
OCFY7.54%
SpS57.43
BVpS15.36
TBVpS-51.41
PEG (NY)1.57
PEG (5Y)2.47
Graham Number80.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROCE | 17.67% | ||
| ROIC | 15.39% | ||
| ROICexc | 17.86% | ||
| ROICexgc | 61.56% | ||
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% | ||
| FCFM | 35.46% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
ROICexc(3y)15.77%
ROICexc(5y)17.27%
ROICexgc(3y)75.76%
ROICexgc(5y)77.1%
ROCE(3y)14.97%
ROCE(5y)16.28%
ROICexgc growth 3Y3.26%
ROICexgc growth 5Y-18.2%
ROICexc growth 3Y-8.67%
ROICexc growth 5Y-7.85%
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
F-Score7
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.3% | ||
| Profit Quality | 182.08% | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | N/A |
F-Score7
WACC8.65%
ROIC/WACC1.78
Cap/Depr(3y)24.77%
Cap/Depr(5y)23.42%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.31%
Profit Quality(3y)165.92%
Profit Quality(5y)155.23%
High Growth Momentum
Growth
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
EPS Next Y9.43%
EPS Next 2Y6.17%
EPS Next 3Y5.25%
EPS Next 5Y4.48%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
Revenue Next Year9.42%
Revenue Next 2Y5.5%
Revenue Next 3Y4.54%
Revenue Next 5Y3.55%
EBIT growth 1Y93.73%
EBIT growth 3Y1.84%
EBIT growth 5Y-0.13%
EBIT Next Year42.82%
EBIT Next 3Y11.34%
EBIT Next 5Y7.32%
FCF growth 1Y36%
FCF growth 3Y7.44%
FCF growth 5Y4.03%
OCF growth 1Y24.04%
OCF growth 3Y7.45%
OCF growth 5Y4.66%
AMGEN INC / 1AMGN.MI FAQ
What is the ChartMill fundamental rating of AMGEN INC (1AMGN.MI) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 1AMGN.MI.
What is the valuation status of AMGEN INC (1AMGN.MI) stock?
ChartMill assigns a valuation rating of 6 / 10 to AMGEN INC (1AMGN.MI). This can be considered as Fairly Valued.
How profitable is AMGEN INC (1AMGN.MI) stock?
AMGEN INC (1AMGN.MI) has a profitability rating of 7 / 10.
What is the valuation of AMGEN INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AMGEN INC (1AMGN.MI) is 14.78 and the Price/Book (PB) ratio is 18.09.
Is the dividend of AMGEN INC sustainable?
The dividend rating of AMGEN INC (1AMGN.MI) is 7 / 10 and the dividend payout ratio is 17.2%.